Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1960 2
1961 1
1962 1
1968 2
1970 1
1982 1
1991 1
1997 3
1998 1
1999 1
2000 1
2001 2
2013 1
2014 2
2016 4
2017 6
2018 7
2019 8
2020 9
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

55 results
Results by year
Filters applied: . Clear all
Page 1
Pulmonary Sarcoidosis.
Bonifazi M, Gasparini S, Alfieri V, Renzoni EA. Bonifazi M, et al. Among authors: alfieri v. Semin Respir Crit Care Med. 2017 Aug;38(4):437-449. doi: 10.1055/s-0037-1603766. Epub 2017 Jul 27. Semin Respir Crit Care Med. 2017. PMID: 28750459 Review. No abstract available.
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial.
Visca D, Mori L, Tsipouri V, Fleming S, Firouzi A, Bonini M, Pavitt MJ, Alfieri V, Canu S, Bonifazi M, Boccabella C, De Lauretis A, Stock CJW, Saunders P, Montgomery A, Hogben C, Stockford A, Pittet M, Brown J, Chua F, George PM, Molyneaux PL, Margaritopoulos GA, Kokosi M, Kouranos V, Russell AM, Birring SS, Chetta A, Maher TM, Cullinan P, Hopkinson NS, Banya W, Whitty JA, Adamali H, Spencer LG, Farquhar M, Sestini P, Wells AU, Renzoni EA. Visca D, et al. Among authors: alfieri v. Lancet Respir Med. 2018 Oct;6(10):759-770. doi: 10.1016/S2213-2600(18)30289-3. Epub 2018 Aug 28. Lancet Respir Med. 2018. PMID: 30170904 Free article. Clinical Trial.
Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression.
Stock CJW, Hoyles RK, Daccord C, Kokosi M, Visca D, De Lauretis A, Alfieri V, Kouranos V, Margaritopoulos G, George PM, Molyneaux PL, Chua F, Maher TM, Abraham DJ, Ong V, Donovan J, Sestini P, Denton CP, Wells AU, Renzoni EA. Stock CJW, et al. Among authors: alfieri v. Respirology. 2021 May;26(5):461-468. doi: 10.1111/resp.13988. Epub 2020 Dec 17. Respirology. 2021. PMID: 33336433
Research highlights from the 2018 ERS International Congress: interstitial lung diseases.
Alfaro TM, Moor CC, Alfieri V, Jeny F, Kreuter M, Wijsenbeek MS, Renzoni EA, Bargagli E, Nunes H, Spagnolo P, Bonella F, Molina-Molina M, Antoniou K, Poletti V. Alfaro TM, et al. Among authors: alfieri v. ERJ Open Res. 2019 Feb 18;5(1):00215-2018. doi: 10.1183/23120541.00215-2018. eCollection 2019 Feb. ERJ Open Res. 2019. PMID: 30792985 Free PMC article. Review.
Next generation beta adrenoreceptor agonists for the treatment of asthma.
Crisafulli E, Frizzelli A, Fantin A, Manco A, Mangia A, Pisi G, Fainardi V, Alfieri V, Aiello M, Bertorelli G, Chetta A. Crisafulli E, et al. Among authors: alfieri v. Expert Opin Pharmacother. 2017 Oct;18(14):1499-1505. doi: 10.1080/14656566.2017.1378348. Epub 2017 Sep 14. Expert Opin Pharmacother. 2017. PMID: 28891349 Review.
Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease.
Alfieri V, Crisafulli E, Visca D, Chong WH, Stock C, Mori L, de Lauretis A, Tsipouri V, Chua F, Kouranos V, Kokosi M, Hogben C, Molyneaux PL, George PM, Maher TM, Chetta AA, Sestini P, Wells AU, Renzoni EA. Alfieri V, et al. Eur Respir J. 2020 Feb 20;55(2):1901681. doi: 10.1183/13993003.01681-2019. Print 2020 Feb. Eur Respir J. 2020. PMID: 31699833 No abstract available.
Cyclophilin A inhibition as potential treatment of human aortic valve calcification.
Perrucci GL, Songia P, Moschetta D, Barbagallo VA, Valerio V, Myasoedova VA, Alfieri V, Massaiu I, Roberto M, Malešević M, Pompilio G, Poggio P. Perrucci GL, et al. Among authors: alfieri v. Pharmacol Res. 2020 Aug;158:104888. doi: 10.1016/j.phrs.2020.104888. Epub 2020 May 17. Pharmacol Res. 2020. PMID: 32434054
55 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page